Abstract
The work summarized in this paper used animal and cell culture models systems to develop gene therapy approaches for the lysosomal storage disorders. The results have provided the scientific basis for a clinical trial of gene transfer to hematopoietic stem cells (HSC) in Gaucher disease which is now in progress. The clinical experiment is providing evidence of HSC transduction, competitive engraftment of genetically corrected HSC, expression of the GC transgene, and the suggestion of a clinical response. In this paper we will review the progress made in Gaucher disease and include how gene transfer might be studied in other lysosomal storage disorders.
Similar content being viewed by others
REFERENCES
Gieselmann, V., A. Polten, J. Kreysing, and K. von Figura. 1994. Molecular genetics of metachromatic leukodystrophy. J. Inher. Met. Dis. 17:500-509.
Kolodny, E.H. and A.L. Fluharty. 1995. Metachromatic Leukodystrophy and multiple sulfatase deficiency: sulfatase lipidosis. In Metabolic basis of inherited disease. Scriver Charles R., Beaudet Arthur L., Sly William S., and Valle David, editors. McGraw-Hill, New York, NY. 2693-2739.
Stein, C., V. Gieselmann, J.X. Kreysing, Schmidt B, R. Pohlmann, A. Waheed, H.E. Meyer, J.S. O'Brien, and K. von Figura. 1989. Cloning and expression of human arylsulfatase A.J. Biol. Chem. 264:1252-1259.
Kreysing, J., K. von Figura, and V. Gieselmann. 1990. Structure of the arylsulfatase A gene. Eur. J. Biochem. 191:627-631.
Kreysing, J., A. Polten, B. Hess, K. von Figura, K. Menz, F.X. Steiner, and V. Gieselmann. 1994. Structure of the mouse arylsulfatase A gene and cDNA. Genomics 19:249-256.
Polten, A., A.L. Fluharty, C.B. Fluharty, J. Kappler, K. von Figura, and V. Gieselmann. 1991. Molecular basis of different forms of metachromatic leukodystrophy. N. Engl. J. Med. 324:18-22.
Hess, B., P. Saftig, D. Hartmann, R. Coenen, R. Lullmann-Rauch, H.H. Goebel, K. von Figura, R. D'Hooge, G. Nagels, P. De Deyn, C. Peters, M. Evers, and V. Gieselmann. 1996. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci., USA 93:14821-14826.
Jinnah, H.A., F.H. Gage, and T. Friedmann. 1991. Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine hosphoribosyltransferase-deficient mouse model of L'esch-Nyhan syndrome. Behav. Neurosci. 105:1004-1012.
De Groot, C.J., W. Huppes, T. Sminia, G. Kraal, and C.D. Dijkstra. 1992. Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous system, using non-radioactive in situ hybridization and immunoperoxidase techniques. GLIA 6:301-309.
Unger, E.R., J.H. Sung, J.C. Manivel, M.L. Chenggis, B.R. Blazar, and W. Krivit. 1993. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J. Neuropath. Exp. Neurol. 52:460-470.
Krall, W.J., P.M. Challita, L.S. Perlmutter, D.C. Skelton, and D.B. Kohn. 1994. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83:2737-2748.
Whitley, C.B., K.G. Belani, P.N. Chang. C.G. Summers, B.R.X. Blazar, Tsai MY, R.E. Latchaw, N.K. Ramsay, and J.H. Kersey. 1993. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am. J. Med. Genet. 46:209-218.
Bergstrom, S.K., J.J. Quinn, R. Greenstein, and J. Ascensao. 1994. Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review. Bone Marrow Transpl. 14:653-658.
Vellodi, A., E. Young, M. New, C. Pot-Mees, and K. Hugh-Jones. 1992. Bone marrow transplantation for Sanfilippo disease type B. J. Inher. Met. Dis. 15:911-918.
Krivit, W., E. Shapiro. W. Kennedy, M. Lipton, L. Lockman, S. Smith, C.G. Summers, D.A. Wenger, M.Y. Tsai, N.K. Ramsay, L.X. Lockman, and et al. 1990. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N. Engl. J. Med. 322:28-32.
Pridjian, G., J. Humbert, J. Willis, and E. Shapira. 1994. Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J. Pediatrics 125:755-758.
Birkenmeier, E.H. 1991. Correction of murine mucopolysaccharidosis type VII (MPS VII) by bone marrow transplantation and gene transfer therapy. Hum. Gene Therapy 2:113.
Marechal, V., N. Naffakh, O. Danos, and J.M. Heard. 1993. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood 82:1358-1365.
Moullier, P., D. Bohl, J.M. Heard, and O. Danos. 1993. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat. Genet. 4:154-159.
Bastedo, L., M.S. Sands, D.T. Lambert, M.A. Pisa, E. Birkenmeier, and P.L. Chang. 1994. Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII. J. Clin. Invest. 94:1180-1186.
Walkley, S.U., M.A. Thrall, K. Dobrenis, M. Huang, P.A. March, D.A. Siegel, and S. Wurzelmann. 1994. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc. Natl. Acad. Sci., USA 91:2970-2974.
Shull, R.M., N.E. Hastings, R.R. Selcer, J.B. Jones, J.R.X. Smith, Cullen WC, and G. Constantopoulos. 1987. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system. J. Clin. Invest. 79:435-443.
Taylor, R.M., G.J. Stewart, B.R. Farrow, Byrne, J, and P.J. Healy. 1989. Histological improvement and enzyme replacement in the brains of fucosidosis dogs after bone marrow engraftment. Transpl. Proc. 21:3074-3075.
Birkenmeier, E.H., J.E. Barker, C.A. Vogler, J.W. Kyle, W.S.X. Sly, Gwynn B, B. Levy, and C. Pegors. 1991. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78:3081-3092.
Leinekugel, P., S. Michel, E. Conzelmann, and K. Sandhoff. 1992. Quantitative correlation between the residual activity of beta-hexosaminidase. A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum. Genet. 88:513-523.
Sands, M.S., J.E. Barker, C. Vogler, B. Levy, B. Gwynn, Galvin, N, W.S. Sly, and E. Birkenmeier. 1993. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68:676-686.
Will, A., A. Cooper, C. Hatton, I.B. Sardharwalla, D.I. Evans, and R.F. Stevens. 1987. Bone marrow transplantation in the treatment of alpha-mannosidosis. Arch. Dis. Childh 62:1044-1049.
Havenga M., Hoogerbrugge P., Valerio D., and van Es H.H.G. 1997. Retroviral stem cell gene therapy. Stem Cells 15:162-179.
Ohashi, T., S. Boggs, P. Robbins, A. Bahnson, K. Patrene, Wei, FS, J.F. Wei, J. Li, L. Lucht, Y. Fei, and et al. 1992. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc. Natl. Acad. Sci., USA 89:11332-11336.
Correll, P.H., S. Colilla, and S. Karlsson. 1994. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Blood 6:1812-1822.
Moore, K.A., A.B. Deisseroth, C.L. Reading, D.E. Williams, and J.W. Belmont. 1992. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393-1399.
Szilvassy, S.J. and S. Cory. 1994. Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 84:74-83.
Mannion-Henderson, J., A. Kemp, M. Nimgaonkar, J. Lancia, M. Beeler, J. Mierski, A.B. Bahnson, E.D. Ball, and J.A. Barranger. 1995. Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors. Exp. Hematol. 23:1628-1632.
Nolta, J.A., E.M. Smogorzewska, and D.B. Kohn. 1995. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101-110.
Xu, L.C., S. Kluepfel-Stahl, M. Blanco, R. Schiffmann, C. Dunbar, and S. Karlsson. 1995. Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients. Blood 86:141-146.
Dunbar, C.E., D.M. Bodine, B. Sorrentino, R. Donahue, McDonagh, K, M. Cottler-Fox, J. O'Shaughnessy, K. Cowan, C. Carter, S. Doren, and et al. 1994. Gene transfer into hematopoietic cells. Implications for cancer therapy. Ann. NY Acad. Sci. 716:216-24.
Bahnson, A.B., J.T. Dunigan, Baysal B.E., Mohney T., Atchison R.W., M.T. Nimgaonkar, E.D. Ball, and J.A. Barranger. 1995. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Meth. 54:131-143.
Nishino, H., T. Hashitani, M. Kumazaki, H. Sato, F.X. Furuyama, Isobe Y, N. Watari, M. Kanai, and S. Shiosaka. 1990. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Brain Res. 534:83-93.
Madrazo, I. and R. Franco-Bourland. 1990. A brain transplant that works. Lancet 335:1283.
Madrazo, I., R. Franco-Bourland, F. Ostrosky-Solis, Aguilera, M, C. Cuevas, C. Zamorano, A. Morelos, E. Magallon, and G. Guizar-Sahagun. 1990. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects. Arch. Neurol. 47:1281-1285.
Madrazo, I., V. Leon, C. Torres, M.C. Aguilera, G.X. Varela, Alvarez F, A. Fraga, R. Drucker-Colin, F. Ostrosky, M. Skurovich, and et al. 1988. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N. Engl. J. Med. 318:51.
Sawle, G.V., P.M. Bloomfield, A. Bjorklund, D.J. Brooks, Brundin, P, K.L. Leenders, O. Lindvall, C.D. Marsden, S.X. Rehncrona, Widner H, and et al. 1992. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann. Neurol. 31:166-173.
Lindvall, O., H. Widner, S. Rehncrona, P. Brundin, P.X. Odin, Gustavii B, R. Frackowiak, K.L. Leenders, G. Sawle, Rothwell, JC, and et al. 1992. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165.
Lindvall, O., P. Brundin, H. Widner, S. Rehncrona, Gustavii, B, R. Frackowiak, K.L. Leenders, G. Sawle, J.C.X. Rothwell, Marsden CD, and et al. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577.
Lindvall, O., S. Rehncrona, P. Brundin, B. Gustavii, Astedt, B, H. Widner, T. Lindholm, A. Bjorklund, K.L. Leenders, J.C. Rothwell, and et al. 1990. Neural transplantation in Parkinson's disease: the Swedish experience. Prog. Brain Res. 82:729-734.
Lindvall, O., S. Rehncrona, P. Brundin, B. Gustavii, Astedt, B, H. Widner, T. Lindholm, A. Bjorklund, K.L. Leenders, J.C. Rothwell, and et al. 1989. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:615-631.
Rosenbluth, J., M. Hasegawa, N. Shirasaki, C.L. Rosen, and Z. Liu. 1990. Myelin formation following transplantation of normal fetal glia into myelin-deficient rat spinal cord. J. Neurocyt. 19:718-730.
Gansmuller, A., Lachapelle F., Baron-Van Evercooren A., Hauw JJ., Baumann N., and M. Gumpel. 1986. Transplantation of newborn CNS fragments into the brain of Shiverer mutant mice: extensive myelination by transplanted oligodendrocytes. Electron microscopic study. Dev. Neurosci. 8:197-207.
Lubetzki, C., A. Gansmuller, F.X. Lachapelle, Lombrail P, and M. Gumpel. 1988. Myelination by oligodendrocytes isolated from 4-6-week-old rat central nervous system and transplanted into newborn shiverer brain. J. Neurol. Sci. 88:161-175.
Gumpel, M., F. Lachapelle, A.X. Gansmuller, Baulac M, A. Baron van Evercooren, and N. Baumann. 1987. Transplantation of human embryonic oligodendrocytes into shiverer brain. Ann. NY Acad. Sci. 495:71-85.
Archer, D.R., S. Leven, and I.D. Duncan. 1994. Myelination by cryopreserved xenografts and allografts in the myelin-deficient rat. Exp. Neurol. 125:268-277.
Noble, M. 1994. The O-2A lineage: from rats to humans. Rec Res Can Res 135:67-75.
Dubois-Dalcq, M. and R.C. Armstrong. 1992. the oligodendrocyte lineage during myelination and remyelination. In Myelin: biology and chemistry. Martenson Russell E. editor. CRC press, Boca Raton, FL. 81-122.
Temple, S. and M.C. Raff. 1985. Differentiation of a bipotential glial progenitor cell in a single cell microculture. Nature 313:223-225.
Miller, R.H., S. David, R. Patel, E.R. Abney, and M.C. Raff. 1985. A quantitative immunohistochemical study of microglial cell development in the rat optic nerve: in vivo evidence for two distinct astrocyte lineages. Dev. Biol. 111:35-41.
McMorris, F.A. and M. Dubois-Dalcq. 1988. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21:199-209.
Noble, M., K. Murray, P. Stroobant, M.D. Waterfield, and P. Riddle. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560-562.
Lillien LE., Sendtner M., and M.C. Raff. 1990. Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocytes development. J. Cell Biol. 111:635-644.
McKinnon, R.D., T. Matsui, M. Dubois-Dalcq, and S.A. Aaronson. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron. 5:603-614.
Bogler, O., D. Wren, S.C. Barnett, H. Land, and M. Noble. 1990. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci., USA 87:6368-6372.
Benveniste, E.N. and J.E. Merrill. 1986. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321:610-613.
Bottenstein, J.E., S.F. Hunter, and M. Seidel. 1988. CNS neuronal cell line-derived factors regulate gliogenesis in neonatal rat brain cultures. J. Neurosci. Res. 20:291-303.
Bottenstein, J.E. and Hunter S. 1990. culture methods for oligodendrocyte-type 2 astrocyte lineage cells. In cell culture. Conn MP, editor. academic press, San Diego. 56-75.
Baulac, M., F. Lachapelle, O. Gout, B. Berger, N. Baumann, and M. Gumpel. 1987. Transplantation of oligodendrocytes in the newborn mouse brain: extension of myelination by transplanted cells. Anatomical study. Brain Res. 420:39-47.
Gansmuller, A., E. Clerin, F. Kruger, M. Gumpel, and F. Lachapelle. 1991. Tracing transplanted oligodendrocytes during migration and maturation in the shiverer mouse brain. GLIA 4:580-590.
Groves, A.K., S.C. Barnett, R.J. Franklin, A.J. Crang, M. Mayer, W.F. Blakemore, and M. Noble. 1993. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362:453-455.
Lachapelle, F., E. Duhamel-Clerin, A. Gansmuller, A.X. Baron-Van Evercooren, Villarroya H, and M. Gumpel. 1994. Transplanted transgenically marked oligodendrocytes survive, migrate and myelinate in the normal mouse brain as they do in the shiverer mouse brain. Eur. J. Neurosci 6:814-824.
Louis, J.C., E. Magal, D. Muir, M. Manthorpe, and S. Varon. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31:193-204.
Tontsch, U., D.R. Archer, M. Dubois-Dalcq, and I.D. Duncan. 1994. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc. Natl. Acad. Sci., USA 91:11616-11620.
Avellana-Adalid, V., B. Nait-Oumesmar, F. Lachapelle, and A. Baron-Van Evercooren. 1996. Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential. J. Neurosci. Res. 45:558-570.
Snyder, E.Y., D.L. Deitcher, C. Walsh, S.X. Arnold-Aldea, Hartwieg EA, and C.L. Cepko. 1992. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51.
Snyder, E.Y., R.M. Taylor, and J.H. Wolfe. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367-370.
Phillips, M.I. 1997. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29:177-187.
Hargrove, P.W., E.F. Vanin, G.J. Kurtzman, and A.W. Nienhuis. 1997. High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3' Y globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 6:2167-2175.
Weitzman, M.D., S.R. Kyostio, R.M. Kotin, and R.A. Owens. 1994. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci., USA 91:5808-5812.
Chiorini, J.A., L. Yang, B. Safer, and R.M. Kotin. 1995. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J. Virol. 69:7334-7338.
Giraud, C., E. Winocour, and K.I. Berns. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69:6917-6924.
Urcelay, E., P. Ward, S.M. Wiener, B. Safer, and R.M. Kotin. 1995. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69:2038-2046.
Walsh, C.E., J.M. Liu, X. Xiao, N.S. Young, A.W. Nienhuis, and R.J. Samulski. 1992. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci., USA 89:7257-7261.
Fisher, K.J., G.P. Gao, M.D. Weitzman, R. DeMatteo, J.F. Burda, and J.M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
Ferrari, F.K., T. Samulski, T. Shenk, and R.J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
Vincent, K.A., S.T. Piraino, and S.C. Wadsworth. 1997. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 71:1897-1905.
Mamounas, M., M. Leavitt, M. Yu, and F. Wong-Staal. 1995. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Gene Therapy 2:429-432.
Chiorini, J.A., C.M. Wendtner, E. Urcelay, B. Safer, M. Hallek, and R.M. Kotin. 1995. High-efficiency transfer of the T cell costimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene. Therapy 6:1531-1541.
Clark, K.R., F. Voulgaropoulou, D.M. Fraley, and P.R. Johnson. 1995. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene. Therapy 6:1329-1341.
Kaplitt, M.G., P. Leone, R.J. Samulski, X. Xiao, D.W. Pfaff, K.L. O'Malley, During, MJ. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
Poduslo, S.E., G. Tennekoon, D. Price, K. Miller, and G.M. McKhann. 1976. Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue. J. Neuropath. Exp. Neurol. 35:622-632.
Baier, W. and K. Harzer. 1983. Sulfatides in prenatal metachromatic leukodystrophy. J. Neurochem. 41:1766-1768.
Adachi, M., L. Schneck, and B.W. Volk. 1974. Ultrastructural studies of eight cases of fetal Tay-Sachs disease. Lab. Invest. 30:102-112.
Kaye, E.M., M.D. Ullman, E.R. Wilson, and J.A. Barranger. 1986. Type 2 and type 3 Gaucher disease: a morphological and biochemical study. Ann. Neurol. 20:223-230.
Schneider, E.L., W.G. Ellis, R.O. Brady, J.R. McCulloch, Epstein, CJ. 1972. Infantile (type II) Gaucher's disease: in utero diagnosis and fetal pathology. J. Pediatr. 81:1134-1139.
Kamoshita, S., M. Odwara, M. Yoshida, M. Owada, and T. Kitagawa. 1976. Fetal pathology and ultrastructure of neuronopathic Gaucher's disease. In Current Trends in Sphingolipidoses and Allied Disorders. B.W. Volk and L. Schneck, editors. Plenum press, New York, 327
Sidransky, E., D.M. Sherer, and E.I. Ginns. 1992. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. [Review] [30 refs]. Pediatric. Res. 32:494-498.
Metcalf, D. and M.A.S. Moore. 1971. Embryonic aspects of haemopoiesis. In Frontiers of Biology-Haematopoietic Cells. A. Neuberger and E.L. Tatum, editors. Amsterdam, North Holland Publishing Co. Amsterdam. pp172
O'Reilly, R.J., M.S. Pollack, N. Kapoor, and et al. 1983. Fetal liver transplantation in man and animals. In Recent advances in bone marrow transplantation. R.G. Gale, editor. Alan R Liss, Inc., New York. pp779
Salami, M.A., M.W. Simpson-Morgan, and B. Morris. 1985. Haemopoiesis and the development of immunologic reactivity in the sheep fetus. In Immunology of the sheep. Anonymous-Editiones Roche, Basil, Switzerland. pp19
Wu, A.M., J.E. Till, L. Siminovitch, and E.A. McCulloch. 1968. Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells of the lymphoid system. J. Exp. Med. 127:455-464.
Lowenberg, B., K.A. Dicke, D.W. van Bekkum, and L.J. Dooren. 1976. Quantitative aspects of fetal liver cell transplantation in animals and man. Transpl. Proc. 8:527-532.
Ekhterae, D., T. Crumbleholme, E. Karson, M.R.X. Harrison, Anderson WF, and E.D. Zanjani. 1990. Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro. Blood 75:365-369.
Rosenthal, P., I.J. Rimm, T. Umiel, J.D. Griffin, Osathanondh, R, S.F. Schlossman, and L.M. Nadler. 1983. Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. J. Immunol. 131:232-237.
Lapidot, T., F. Pflumio, M. Doedens, B. Murdoch, D.E. Williams, and J.E. Dick. 1992. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-1141.
Turner, J.H., D.L. Hutchinson, and J.C. Petricciani. 1973. Chimerism following fetal transfusion. Report of leukocyte hybridization and infant with acute lymphocyte leukemia. Scand. J. Hematol. 10:358-366.
Szymanski, I.O., C.A. Tilley, M.C. Crookston, and T.J.X. Greenwalt, Moore S. 1977. A further example of human blood group Chimerism. J. Med. Genet. 14:279-281.
Billingham, R.E., L. Brent, and P.B. Medawai. 1953. Actively acquired tolerance of foreign cells. Nature 172:603-606.
Binns, R.M. 1967. Bone marrow and lymphoid cell injection of the pig fetus resulting in transplantation tolerance or immunity, and immunoglobulin production. Nature 214:179-180.
Roncarolo, M.G. and B. Vandekerckhove. 1992. SCID-hu mice as a model to study tolerance after fetal stem cell transplantation. Bone Marrow Transpl. 9Suppl 1:83-84.
Touraine, J.L., M.G. Roncarolo, R. Bacchetta, D.X. Raudrant, Rebaud A, S. Laplace, P. Cesbron, L. Gebuhrer, M.T.X. Zabot, Touraine F, and et al. 1993. Fetal liver transplantation: biology and clinical results [Review] [5 refs]. Bone Marrow Transpl. 11Suppl 1:119-122.
Wolfe, J.H., M.S. Sands, J.E. Barker, B. Gwynn, L.B. Rowe, C.A. Vogler, and E.H. Birkenmeier, 1992. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360:749-753.
Bansal, V., P. Mowery-Rushton, L. Lucht, J. Li, A.X. Bahnson, Watkins SC, and J.A. Barranger. 1994. Transduction, expression, and secretion of human glucocerebrosidase by murine myoblasts. Ann. NY Acad. Sci. 716:307-19.
Danos, O. and R.C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci., USA 85:6460-6464.
Miller, A.D. and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
Ohashi, T., Y. Eto, R. Learish, and J.A. Barranger. 1993. Correction of enzyme deficiency in metachromatic leukodystrophy fibroblasts by retroviral-mediated transfer of the human arylsulphatase A gene. J. Inher. Met. Dis. 16:881-885.
Learish, R., T. Ohashi, P.A. Robbins, A. Bahnson, S.S. Boggs, K.X. Patrene, Schwartz BE, V. Gieselmann, and J.A. Barranger. 1996. Retroviral gene transfer and sustained expression of human arylsulfatase A. Gene Therapy 3:343-349.
Wei, J.F., F.S. Wei, R.J. Samulski, and J.A. Barranger. 1994. Expression of the human glucocerebrosidase and arylsulfatase A genes in murine and patient primary fibroblasts transduced by an adeno-associated virus vector. Gene Therapy 1:261-268.
Scott, J.E., C.R. Orford, and E.W. Hughes. 1981. Proteoglycan-collagen arrangements in developing rat tail tendon. An electron microscopical and biochemical investigation. Biochem. J. 195:573-581.
Walkley, S.U., M.A. Thrall, K. Dobrenis, P. March, and S. Wurzelmann. 1994. Bone marrow transplantation in neuronal storage diseases. Brain Pathol 4:376
Dobrenis, K., D.A. Wenger, and S.U. Walkley. 1994. Extracellular release of lysosomal glycosidases in culture of cat microglia. Mol. Biol. cell 5:113A
Perry, V.H. 1994. Macrophages and the nervous system. Austin: R G Landes Company, 6 pp.
Eppig, J.J., L.P. Kozak, E.M. Eicher, and L.C. Stevens. 1977. Ovarian teratomas in mice are derived from oocytes that have completed the first meiotic division. Nature 269:517-518.
Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
Neuwelt, E.A., J.A. Barranger, M.A. Pagel, J.M. Quirk, R.O.X. Brady, and E.P. Frenkel. 1984. Delivery of active hexosaminidase across the blood-brain barrier in rats. Neurology 34:1012-1019.
Hickey, W.F. and H. Kimura. 1982. Perivascular microglia cells of the CNS are bone marrow derived and present antigens in vivo. Science 239:290-292.
Bartlett, P.F. 1982. Pluripotential hemopoietic stem cells in adult mouse brain. Proc. Natl. Acad. Sci., USA 79:2722-2725.
Bayever, E., S. Ladisch, M. Philippart, N. Brill, M.X. Nuwer, Sparkes RS, and S.A. Feig. 1985. Bone-marrow transplantation for metachromatic leukodystrophy. Lancet 2:471-473.
Hobbs, J.R. 1985. Correction of 34 genetic diseases by displacement bone marrow transplantation. Plasma Ther. transfus Technol. 6:221-246.
Taylor, R.M., B.R.L. Farrow, G.J. Steward, P.J. Healy, and K. Tivier. 1987. Lysosomal enzyme replacement in neural tissue by allogeneic bone marrow transplantation following total lymphoid irradiation in canine fucosidisis. Transplant. Proc. 19:2730-2734.
Hoogerbrugge, P.M., B.J.H.M. Poorthuis, J.M.J.J. Vossen, L.J. Dooren, G. Wagenmaker, and D.W. van Bekkum. 1987. Bone marrow transplantation in murine lysosomal storage disease. Exp. Hematol. 15:616a
Schull, R.M., M.A. Breider, and G.C. Constantopulos. 1988. Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease. Pediatric Res. 24:347-352.
Mowery-Rushton, P.A., L. Lucht, J. Li, M.J. Vallor, Bansal, V, and J.A. Barranger. 1993. Expression of glucocerebrosidase in the brain following transplantation of transduced bone marrow in mice. Society of Pediatric Research, Washington, D.C. Abstract.